Shepherd Kaplan Krochuk’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-9,934
Closed -$523K 235
2018
Q1
$523K Hold
9,934
0.32% 96
2017
Q4
$462K Hold
9,934
0.29% 101
2017
Q3
$402K Hold
9,934
0.33% 89
2017
Q2
$337K Hold
9,934
0.2% 119
2017
Q1
$288K Hold
9,934
0.15% 131
2016
Q4
$326K Sell
9,934
-11,438
-54% -$343K 0.09% 118
2016
Q3
$674K Hold
21,372
0.14% 92
2016
Q2
$601K Sell
21,372
-3,209
-13% -$126K 0.15% 92
2016
Q1
$894K Buy
24,581
+11,079
+82% +$391K 0.28% 57
2015
Q4
$540K Hold
13,502
0.14% 113
2015
Q3
$385K Sell
13,502
-6,193
-31% -$204K 0.1% 154
2015
Q2
$649K Buy
19,695
+2,999
+18% +$93K 0.12% 142
2015
Q1
$480K Hold
16,696
0.08% 182
2014
Q4
$455K Hold
16,696
0.07% 216
2014
Q3
$356K Buy
16,696
+1,340
+9% +$30.7K 0.05% 265
2014
Q2
$345K Sell
15,356
-11,974
-44% -$279K 0.04% 280
2014
Q1
$691K Hold
27,330
0.08% 177
2013
Q4
$628K Buy
27,330
+11,974
+78% +$250K 0.08% 180
2013
Q3
$293K Hold
15,356
0.05% 304
2013
Q2
$221K Buy
+15,356
New +$222K 0.04% 397

Other funds holding EBS

Shepherd Kaplan Krochuk's EBS Position: Q2 2018 in Review

Shepherd Kaplan Krochuk sold out of Emergent Biosolutions (EBS) in Q2 2018, closing a stake of 9,934 shares — an estimated $523K sold.

Shepherd Kaplan Krochuk first reported a position in EBS in Q2 2013 and held it in 20 quarters. The position peaked at $894K in Q1 2016. 263 funds tracked by Wall St. Rank hold EBS as of Q2 2018.

  • Shepherd Kaplan Krochuk reported no remaining Emergent Biosolutions position as of Q2 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 9,934 Emergent Biosolutions shares in Q2 2018, an estimated $523K.
  • Shepherd Kaplan Krochuk first reported a position in Emergent Biosolutions in Q2 2013 and held it in 20 quarters.
  • Shepherd Kaplan Krochuk's Emergent Biosolutions position peaked at $894K in Q1 2016.
  • 263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2018, filed 14 Aug 2018.